NCT00668005View on ClinicalTrials.gov

Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

September 30, 2003

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

5mg, 10mg or 20mg taken 1h before sexual intercourse

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY

NCT00668005 - Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension | Biotech Hunter | Biotech Hunter